Mandatory Notification of Trade
Reference is made to the stock exchange notice published by Bionor Pharma ASA (“Bionor” or the “Company”) published at 07:30 CET today. Bionor announces that members of the Company’s Board of Directors and Management participated in the Company’s Private Placement and purchased a total of 77,660 shares at NOK 2.35 per share.
• Deputy Chairman Øystein Soug purchased 27,660 shares through his Company Abakus Invest AS and controls after the transaction
a total of 107,205 shares in the Company
• CEO Anker Lundemose purchased 25,000 shares and controls after the transaction a total of 125,000 shares in the Company
• CFO Synne H. Røine purchased 25,000 shares and controls after the transaction a total of 50,000 shares in the Company
This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Securities Trading Act).
Bionor Pharma ASA
Synne H Røine
Tel +47 99 22 98 92